本周,跨国药企陆续发布2025年H1财报,业绩大比拼一触即发。几家药企凭借自身实力,财报数据喜人。阿斯利康H1营收280亿美元增11%,其中Enhertu卖出22.89亿美元;赛诺菲营收198.89亿欧元,同比增长9.9%,尤其是度普利尤单抗大卖80亿美元。另一方面,也有一些大型药企表现不及预期,例如默沙东上半年营收313.3亿美元,同比降低2%。同时,诺和诺德宣布将下调业绩全年预期,其股价应声...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.